Histone deacetylation is directly involved in desilencing the expression of the catalytic subunit of telomerase in normal lung fibroblast
- PMID: 16202213
- PMCID: PMC6741419
- DOI: 10.1111/j.1582-4934.2005.tb00496.x
Histone deacetylation is directly involved in desilencing the expression of the catalytic subunit of telomerase in normal lung fibroblast
Abstract
The regulation of telomerase expression in normal cells is poorly understood. Moreover, the molecular mechanism underlying tumor-specific expression of telomerase remains unclear. We investigated the link between histone deacetylation and telomerase activity in normal lung and lung tumor cells. Four non-small-cell lung cancer (NSCLC) lines and one normal lung fibroblast line were tested for telomerase activity with or without Trichostatin A(TSA). The telomerase activity and the expression of telomerase associated components were determined by TRAP assay, RT-PCR analysis and Western blot analysis. All 4 NSCLC cell lines exposed to 1 microM TSA for 24 h had no change in telomerase activity or hTERT mRNA level. Telomerase activity was very low in normal lung fibroblasts (mrc-9) until exposed to 1 microM TSA for 24 h, at which time telomerase activity was readily detectable, with concomitant upregulation of hTERT mRNA (10-fold). The level of other telomerase associated components (hTER and TP1) were unaltered. Furthermore, 1 microM TSA exposure for 24 h did not alter the level of c-Myc or p21 mRNA. Immunodetection reveled that hTERT protein expression increased (approximately 6 fold) compared to c-Myc, p21, or gelsolin. The effect of TSA on hTERT expression is independent of DNA methylation as judged by 5-azacytidine (5aza) treatment. TSA effect on mrc-9 cells is unaltered even in the presence of 200 microg/ml cyclohexamide, suggesting a direct inhibition of histone deacetylation. Collectively, our study indicates that inhibition of histone deacetylation selectively regulates the transcriptional derepression of telomerase catalytic subunit in normal lung fibroblast cells compared to lung tumor cells.
Similar articles
-
Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells.Int J Cancer. 2002 Feb 10;97(5):621-5. doi: 10.1002/ijc.10082. Int J Cancer. 2002. PMID: 11807787
-
The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.Exp Cell Res. 2002 Mar 10;274(1):25-34. doi: 10.1006/excr.2001.5462. Exp Cell Res. 2002. PMID: 11855854
-
Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor.Biochem Biophys Res Commun. 2005 Sep 16;335(1):36-44. doi: 10.1016/j.bbrc.2005.07.039. Biochem Biophys Res Commun. 2005. PMID: 16051188
-
Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells.Mutat Res. 2007 Dec 1;625(1-2):134-44. doi: 10.1016/j.mrfmmm.2007.06.005. Epub 2007 Jun 26. Mutat Res. 2007. PMID: 17669439
-
Expression of telomerase genes in thyroid carcinoma.Int J Oncol. 2002 Aug;21(2):265-72. Int J Oncol. 2002. PMID: 12118320 Review.
Cited by
-
Epigenetic programming of mesenchymal stem cells from human adipose tissue.Stem Cell Rev. 2006;2(4):319-29. doi: 10.1007/BF02698059. Stem Cell Rev. 2006. PMID: 17848719 Review.
-
Differential expression of epigenetic modulators during human embryonic stem cell differentiation.Mol Biotechnol. 2009 Mar;41(3):201-7. doi: 10.1007/s12033-008-9118-8. Epub 2008 Oct 25. Mol Biotechnol. 2009. PMID: 18953677 Free PMC article.
-
Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets.Int J Mol Sci. 2021 Oct 28;22(21):11701. doi: 10.3390/ijms222111701. Int J Mol Sci. 2021. PMID: 34769131 Free PMC article. Review.
-
The regulation of telomerase in oncogenesis.Acta Naturae. 2009 Apr;1(1):51-67. Acta Naturae. 2009. PMID: 22649586 Free PMC article.
References
-
- Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblast. Nature 1990; 345: 458–60. - PubMed
-
- Greider CW. Telomere length regulation. Annu Rev Biochem. 1996; 65: 337–65. - PubMed
-
- Kim NW, Piatyszek MA, Prowse KR, Harley CB, West, MD , Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011–5. - PubMed
-
- Oulton R, Harrington L. Telomeres, telomerase, and cancer: life on the edge of genomic stability. Curr Opin Oncology 2000; 12: 74–81. - PubMed
-
- Hyman K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, et al. Actvation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol. 1995; 155: 3711–5. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials